Bottom line
SHISX vs HGHAX: the short answer
SHISX (Blackrock Health Sciences Opportunities Portfolio) and HGHAX (The Hartford Healthcare Fund) are both mutual funds.
SHISX is cheaper at 1.16% vs 1.33% — a difference of $17 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
SHISX vs HGHAX side by side
| SHISX | HGHAX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.16% | 1.33% |
| Annual cost per $10k | $116 | $133 |
| 10-yr cost on $10k (prospectus) | $1,409 | $2,063 |
| Max front load | — | 5.5% |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +15.9% | — |
| 5-yr return (annualized) | +5.5% | — |
| 10-yr return (annualized) | +9.5% | — |
| Best quarter | +17.5% | +20.9% |
| Worst quarter | −11.5% | −15.7% |
| Net assets (fund) | $5.9B | $772.2M |
| Number of holdings | 155 | 80 |
| Portfolio turnover | 49% | 49% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHISX | HGHAX | Difference |
|---|---|---|---|
| 2025 | +15.9% | +15.6% | +0.3% |
| 2024 | +3.8% | 0.0% | +3.8% |
| 2023 | +3.5% | +3.8% | −0.3% |
| 2022 | −6.0% | −11.7% | +5.8% |
| 2021 | +11.7% | +10.0% | +1.8% |
| 2020 | +19.4% | +22.6% | −3.2% |
| 2019 | +25.3% | +33.3% | −8.0% |
| 2018 | +8.0% | −3.0% | +11.0% |
| 2017 | +24.8% | +21.6% | +3.2% |
| 2016 | −6.1% | −8.6% | +2.5% |
Source: Fund prospectus bar charts
Holdings overlap
17 of SHISX's top 25 holdings also appear in HGHAX's top 25.
| Holding | SHISX | HGHAX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 12.03% |
| Johnson & Johnson | 8.77% | 6.75% |
| Unitedhealth Group Inc | 6.10% | 4.74% |
| Merck & Company Inc | 4.94% | 6.00% |
| Abbvie Inc | 3.94% | 4.21% |
| Amgen Inc | 3.37% | 1.39% |
| Thermo Fisher Scientific Inc | 3.02% | 1.58% |
| Vertex Pharmaceuticals Inc | 2.74% | 2.64% |
| Edwards Lifesciences Corp | 2.51% | 2.48% |
| Danaher Corp | 2.00% | 2.57% |
| Abbott Laboratories | 1.97% | 1.82% |
| Intuitive Surgical Inc | 1.95% | 2.88% |
| Boston Scientific Corp | 1.59% | 1.88% |
| Elevance Health Inc | 1.56% | 3.00% |
| Biogen Inc | 1.21% | 1.36% |
Source: SEC Form N-PORT
SHISX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
FAQ
What is the difference between SHISX and HGHAX?
Which is cheaper, SHISX or HGHAX?
Should I own both SHISX and HGHAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.